Biotechgate Digital Partnering August 2026

Biotechgate Digital Partnering August 2026
Go back

BIOTECHGATE DIGITAL PARTNERING

Virtual business development & licensing event | Aug 31 – Sep 4, 2026

Biotechgate Digital Partnering is focusing on companies developing drugs, diagnostics and medical devices. The main objective of the event is to provide a platform for business development in the field of licensing and collaboration.

CONFERENCE PROGRAM

Biotechgate Digital Partnering offers you a complete conference program as a virtual experience, including virtual one-on-one meetings, Pop-up Coffee sessions as well as workshops and presentations.

Digital Partnering

The scheduling of individual one-on-one meetings is provided by our premium partnering and matchmaking platform HelloPartnering.

  • 5 days of Digital Partnering: Contact and arrange meetings with representatives of leading companies active in the Biotech and Pharma industry. See who is attending »
  • Attend your pre-scheduled meetings via Zoom video calls. Learn more about the partnering »
  • Privacy is guaranteed: Every virtual meeting takes place in its own, secure virtual room.
Free registration

To support the business development in the Biotech, Medtech and Pharma industry, we are making this partnering event available for free to companies interested in participating. As a member company of any of our Biotechgate partners, you get free Premium Access to Biotechgate Digital Partnering. If you are not a member of any of our partners, you still get free access with some limitations and a possibility to upgrade.

More details about the partnering are available in the FAQ and Registration sections further down on this page.

BioRN members receive a free Premium Access to Biotechgate Digital Partnering .

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
How is TR-FRET Used in Drug Discovery?

How is TR-FRET Used in Drug Discovery?

This post is Part 2 of a two-part blog series. Read part 1: What is a TR‑FRET assay and how is it used in drug discovery? In a previous blog post, we covered the fundamental principles of Time-Resolved Fluorescence (TR) Förster Resonance Energy Transfer (TR-FRET), including how long-lived lanthanide donors like europium enable high-sensitivity, “mix-and-read” assays. Because TR-FRET provides a ratiometric, proximity-based […]

read more
Triple ERC Success at the German Cancer Research Center

Triple ERC Success at the German Cancer Research Center

Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine. With the funding, they plan to investigate why certain brain […]

read more
Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM) have identified a previously unknown mechanism that can drive cancer cachexia – a wasting process in the body that primarily affects muscle and fat tissue. A central role is […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp